Instrument Inactif

Autres langues Danaher Corporation NYSE

Actions

DHR PRB

US2358514097

Equipement et technologie médicale avancés

Autres langues

15/09	Danaher Corporation Approves Quarterly Cash Dividend, Payable on October 30, 2026
15/09	Danaher Keeps Quarterly Dividend at $0.40 Per Share, Payable Oct. 30 to Shareholders of Record Sept. 30
15/09	Danaher Announces Quarterly Dividend
09/09	Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says
24/08	Qiagen macht Jonathan Pratt zum neuen Konzernchef
24/08	Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages
17/08	Merck KGaA erhält Bundeskartellamt-Freigabe für Übernahme von Bio-Techne
04/08	Morning meeting: Wall Street vuelve a apostar por los "Siete Magníficos"
04/08	Morning Meeting: Wall Street entdeckt die "Magnificent Seven" wieder
04/08	Wall Street Reconnects with the Magnificent Seven
03/08	Danaher Appoints Julie Sawyer Montgomery as CEO
03/08	Danaher names insider Julie Sawyer Montgomery as CEO
03/08	Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
03/08	Danaher Corporation Announces CEO Changes, Effective October 1, 2026
03/08	Danaher Corporation Announces Board and Management Changes, Effective October 1, 2026
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
23/07	Sartorius nach Quartalsbericht wieder abwärts
23/07	ROUNUP 2: Labordienstleister Sartorius nimmt Fahrt auf - Zollrückzahlungen
23/07	Thermo Fisher raises annual profit forecast as customer demand improves
22/07	Danaher Posts Mixed Q2 Results, Outlook for 2027 and Beyond Strengthened, RBC Says
22/07	Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
22/07	MORNING BRIEFING - USA/Asien
22/07	MORNING BRIEFING - Deutschland/Europa -2-
22/07	MORNING BRIEFING - Deutschland/Europa
21/07	Danaher Corporation Provides Revenue Guidance for the Third Quarter 2026